Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Myofunctional therapy for children with obstructive sleep apnea

Official title: Myofunctional Therapy for Children With Obstructive Sleep Apnoea - a Multi-centre Randomised Controlled Trial

Run by Chinese University of Hong Kong · NCT07249944 · Data updated 2026-11-12

This study tests whether myofunctional therapy helps children aged 6–12 who have obstructive sleep apnea see improvements in sleep and breathing.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment174 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Shatin)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedOctober 21, 2026
Trial IDNCT07249944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 years with clinically diagnosed OSA confirmed by polysomnography (oAHI ≥ 1/hour).

Probably not a fit

Some children may not respond to myofunctional therapy or may have OSA primarily driven by factors not addressed by MFT.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study investigates the efficacy of myofunctional therapy as an adjunct treatment for pediatric obstructive sleep apnea. Eligible children aged 6–12 with diagnosed OSA will receive structured myofunctional exercises, with outcome measures including sleep parameters and airway function. The trial builds on limited prior evidence from smaller studies and seeks to provide more robust data, including the potential role of remote guidance. The study aims to address gaps such as follow-up duration and the effect on craniofacial structure. It is conducted under the auspices of the Chinese University of Hong Kong and collaborating Hong Kong hospitals.

Why it matters

Potential benefit: If successful, children may experience better sleep quality and reduced airway obstruction related to OSA.

How similar studies have gone: Previous small studies and case-control data suggested improvement with MFT, but high-quality randomized trials are limited; this trial seeks to provide clearer evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Children aged 6-12 years, with this age range, children start to have a greater ability to understand and follow instructions, making them more likely to comply and cooperate with the treatment procedures, and at the same time this age range remains a critical and modifiable developmental window when interventions can address underlying orofacial muscle and respiratory muscle dysfunctions and enhance the potential for long-term benefits.
2. Diagnosed with OSA based on clinical evaluation and polysomnography (oAHI ≥ 1/hour). The clinical evaluation will involve assessing the presence of habitual snoring, which is defined as snoring occurring 3 nights or more per week on average as reported by parents or caregivers, and any of the following features suggestive of SDB such as oral breathing, respiratory pauses, observed apnoeas, or increased work of breathing during sleep. Children with persistent OSA, documented by repeat PSG, can be included after receiving standard treatments (such as adenotonsillectomy treatment).
3. Informed consent from a parent or a legal guardian.

Exclusion Criteria:

* Genetic, syndromal, or metabolic disease
* Congenital or acquired neuromuscular disease
* Syndromal craniofacial abnormalities or previous craniofacial surgery
* Severe developmental delay (developmental or functional age \<66% of chronological age)
* Children with OSA who are indicated for and will receive other treatments such as adenotonsillectomy, positive airway pressure therapy or orthodontic treatment.

Where it's running

  • Prince of Wales Hospital, The Chinese University of Hong Kong
    Shatin, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Ching Ching, Kate CHAN, MD — Chinese University of Hong Kong
  • Study coordinator: Ching Ching, Kate CHAN, MD
  • Email: katechan@cuhk.edu.hk
  • Phone: (852) 3505 3515

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.